IFNG and neoplasm: In addition, Garnett et al. reported that DOC could modulate CD4+, CD8+, CD19+, natural killer cells, and Treg populations in non-tumor-bearing mice, and enhance IFN-γ production by CD8+ T cells in a healthy murine model [8].